{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T16:40:35Z","timestamp":1766940035079},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00105-013-2594-1","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T04:59:45Z","timestamp":1382417985000},"page":"752-756","source":"Crossref","is-referenced-by-count":9,"title":["Off-label-Indikationen f\u00fcr topisches Tacrolimus"],"prefix":"10.1007","volume":"64","author":[{"given":"U.R.","family":"Hengge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,20]]},"reference":[{"key":"2594_CR1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0190-9622(03)02157-1","volume":"50","author":"Bamford","year":"2004","unstructured":"Bamford JT, Elliott BA, Haller IV (2004) Tacrolimus effect on rosacea. J Am Acad Dermatol 50:107\u2013108","journal-title":"J Am Acad Dermatol"},{"key":"2594_CR2","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1046\/j.1365-2133.2003.05383.x","volume":"148","author":"Braza","year":"2003","unstructured":"Braza TJ, DiCarlo JB, Soon SL, McCall CO (2003) Tacrolimus 0.1\u2009% ointment for seborrhoeic dermatitis: an open-label pilot study. Br J Dermatol 148:1242\u20131244","journal-title":"Br J Dermatol"},{"key":"2594_CR3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2133.2004.06043.x","volume":"151","author":"Connolly","year":"2004","unstructured":"Connolly M, Kennedy C (2004) Exfoliative cheilitis successfully treated with topical tacrolimus. Br J Dermatol 151:241\u2013242","journal-title":"Br J Dermatol"},{"key":"2594_CR4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0190-9622(99)70496-2","volume":"40","author":"Dahlman-Ghozlan","year":"1999","unstructured":"Dahlman-Ghozlan K, Hedblad MA, Krogh G von (1999) Penile lichen sclerosus et atrophicus treated with clobetasol dipropionate 0.05\u2009% cream: a retrospective clinical and histopathological study. J Am Acad Dermatol 40:451\u2013457","journal-title":"J Am Acad Dermatol"},{"key":"2594_CR5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2133.2004.05985.x","volume":"150","author":"Dirschka","year":"2004","unstructured":"Dirschka T, Tronnier H, F\u00f6lster-Holst R (2004) Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol 150:1136\u20131141","journal-title":"Br J Dermatol"},{"key":"2594_CR6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.eururo.2008.03.013","volume":"54","author":"Ebert","year":"2008","unstructured":"Ebert AK, R\u00f6sch WH, Vogt T (2008) Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. Eur Urol 54:932\u2013937","journal-title":"Eur Urol"},{"key":"2594_CR7","first-page":"267","volume":"73","author":"Freeman","year":"2004","unstructured":"Freeman AK, Serle J, Van Veldhuisen P et al (2004) Tacrolimus ointment in the treatment of eyelid dermatitis. Cutis 73:267\u2013271","journal-title":"Cutis"},{"key":"2594_CR8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1067\/mjd.2001.114739","volume":"44","author":"Goldman","year":"2001","unstructured":"Goldman D (2001) Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 44:995\u2013998","journal-title":"J Am Acad Dermatol"},{"key":"2594_CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","volume":"51","author":"Grimes","year":"2004","unstructured":"Grimes PE et al (2004) Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 51:52\u201361","journal-title":"J Am Acad Dermatol"},{"key":"2594_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","volume":"54","author":"Hengge","year":"2006","unstructured":"Hengge UR, Ruzicka T, Schwartz RA, Cork MJ (2006) Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 54:1\u201315","journal-title":"J Am Acad Dermatol"},{"key":"2594_CR11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1365-2133.2006.07446.x","volume":"155","author":"Hengge","year":"2006","unstructured":"Hengge UR, Krause W, Hofmann H et al (2006) Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 155:1021\u20131028","journal-title":"Br J Dermatol"},{"key":"2594_CR12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2230.2004.01632.x","volume":"29","author":"Kanwar","year":"2004","unstructured":"Kanwar AJ et al (2004) Topical tacrolimus for treatment of childhood vitiligo in Asians. Clin Exp Dermatol 29:589\u2013592","journal-title":"Clin Exp Dermatol"},{"key":"2594_CR13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000051700","volume":"203","author":"Kawakami","year":"2001","unstructured":"Kawakami T, Soma Y, Morita E et al (2001) Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation. Dermatology 203:32\u201337","journal-title":"Dermatology"},{"key":"2594_CR14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","volume":"139","author":"Lepe","year":"2003","unstructured":"Lepe V et al (2003) A double-blind randomized trial of 0.1\u2009% tacrolimus vs 0.05\u2009% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 139:581\u2013585","journal-title":"Arch Dermatol"},{"key":"2594_CR15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archderm.142.7.927","volume":"142","author":"Mehrabi","year":"2006","unstructured":"Mehrabi D, Pandya AG (2006) A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus 0.1\u2009% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo. Arch Dermatol 142:927\u2013929","journal-title":"Arch Dermatol"},{"key":"2594_CR16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(03)13863-9","volume":"362","author":"Oyama","year":"2003","unstructured":"Oyama N, Chan I, Neill SM et al (2003) Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 362:118\u2013123","journal-title":"Lancet"},{"key":"2594_CR17","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archderm.140.9.1065","volume":"140","author":"Passeron","year":"2004","unstructured":"Passeron T et al (2004) Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol 140:1065\u20131069","journal-title":"Arch Dermatol"},{"key":"2594_CR18","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(98)08228-2","volume":"353","author":"Powell","year":"1999","unstructured":"Powell JJ, Wojnarowska F (1999) Lichen sclerosus. Lancet 353:1777\u20131783","journal-title":"Lancet"},{"key":"2594_CR19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2004.05.036","volume":"51","author":"Silverberg","year":"2004","unstructured":"Silverberg NB et al (2004) Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol 51:760\u2013766","journal-title":"J Am Acad Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-013-2594-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2594-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:38:02Z","timestamp":1558568282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-013-2594-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["2594"],"URL":"https:\/\/doi.org\/10.1007\/s00105-013-2594-1","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}